Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,436
Closed -$1.07M 114
2024
Q2
$1.07M Sell
3,436
-549
-14% -$161K 0.06% 151
2024
Q1
$1.13M Hold
3,985
0.09% 155
2023
Q4
$1.15M Hold
3,985
0.06% 149
2023
Q3
$1.07M Hold
3,985
0.06% 167
2023
Q2
$885K Hold
3,985
0.05% 205
2023
Q1
$963K Sell
3,985
-8,084
-67% -$1.98M 0.05% 192
2022
Q4
$3.17M Buy
12,069
+7,959
+194% +$2.13M 0.19% 64
2022
Q3
$926K Hold
4,110
0.06% 177
2022
Q2
$1M Hold
4,110
0.07% 171
2022
Q1
$994K Hold
4,110
0.06% 197
2021
Q4
$925K Buy
4,110
+1,592
+63% +$336K 0.06% 232
2021
Q3
$533K Sell
2,518
-4,826
-66% -$1.11M 0.04% 390
2021
Q2
$1.79M Hold
7,344
0.12% 115
2021
Q1
$1.83M Sell
7,344
-358
-5% -$85.4K 0.13% 101
2020
Q4
$1.77M Sell
7,702
-4,468
-37% -$1.03M 0.14% 102
2020
Q3
$3.09M Buy
12,170
+6,991
+135% +$1.73M 0.26% 58
2020
Q2
$1.22M Buy
5,179
+3,949
+321% +$901K 0.15% 67
2020
Q1
$249K Buy
+1,230
New +$269K 0.06% 232
2019
Q4
Sell
-1,494
Closed -$289K 326
2019
Q3
$289K Sell
1,494
-339
-18% -$65.1K 0.06% 254
2019
Q2
$338K Sell
1,833
-5,244
-74% -$939K 0.07% 227
2019
Q1
$1.34M Buy
7,077
+2,008
+40% +$383K 0.23% 56
2018
Q4
$987K Buy
+5,069
New +$989K 0.25% 60

Other funds holding AMGN

Symmetry Partners's AMGN Position: Q3 2024 in Review

Symmetry Partners sold out of Amgen (AMGN) in Q3 2024, closing a stake of 3,436 shares — an estimated $1.07M sold.

Symmetry Partners first reported a position in AMGN in Q4 2018 and held it in 22 quarters. The position peaked at $3.17M in Q4 2022. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Symmetry Partners reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
  • Symmetry Partners sold 3,436 Amgen shares in Q3 2024, an estimated $1.07M.
  • Symmetry Partners first reported a position in Amgen in Q4 2018 and held it in 22 quarters.
  • Symmetry Partners's Amgen position peaked at $3.17M in Q4 2022.
  • 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Symmetry Partners's 13F filing for Q3 2024, filed 29 Oct 2024.